60.61
price up icon0.05%   0.03
after-market 시간 외 거래: 60.60 -0.010 -0.02%
loading
전일 마감가:
$60.58
열려 있는:
$60.41
하루 거래량:
224.40K
Relative Volume:
0.60
시가총액:
$2.10B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-16.51
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
+4.92%
1개월 성능:
+12.42%
6개월 성능:
+5.50%
1년 성능:
+38.00%
1일 변동 폭
Value
$59.47
$60.83
1주일 범위
Value
$57.42
$61.73
52주 변동 폭
Value
$30.82
$68.73

Disc Medicine Inc Stock (IRON) Company Profile

Name
명칭
Disc Medicine Inc
Name
전화
(617) 674-9274
Name
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
Name
직원
84
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
IRON's Discussions on Twitter

IRON을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IRON
Disc Medicine Inc
60.61 2.10B 0 -91.00M -74.38M -3.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-21 개시 Truist Buy
2025-07-03 재개 Morgan Stanley Overweight
2025-06-11 재개 Raymond James Strong Buy
2025-02-27 개시 TD Cowen Buy
2024-11-05 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-11-04 업그레이드 Raymond James Outperform → Strong Buy
2024-10-23 개시 Jefferies Buy
2024-10-16 개시 Scotiabank Sector Outperform
2024-08-22 개시 Wells Fargo Overweight
2024-04-01 다운그레이드 Raymond James Strong Buy → Outperform
2023-12-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-06-09 업그레이드 Raymond James Outperform → Strong Buy
2023-06-07 개시 H.C. Wainwright Buy
2023-05-17 개시 Raymond James Outperform
2023-04-28 개시 Cantor Fitzgerald Overweight
2023-04-21 개시 Stifel Buy
2023-04-20 개시 Morgan Stanley Overweight
2023-03-23 개시 BMO Capital Markets Outperform
2023-02-28 개시 SVB Securities Outperform
모두보기

Disc Medicine Inc 주식(IRON)의 최신 뉴스

pulisher
Jul 25, 2025

Insider Selling at Disc Medicine Inc.: A Balancing Act Between Portfolio Strategy and Investor Sentiment - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Is Disc Medicine Inc. a good long term investmentFree Stock Movement Tracking - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Can Disc Medicine Inc. stock recover from recent declineSuperior profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Disc Medicine Inc. stock priceBreakthrough capital growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

10 Best Mid Cap Stocks to Buy According to Billionaires - Insider Monkey

Jul 25, 2025
pulisher
Jul 24, 2025

Is Disc Medicine Inc. stock overhyped or has real potentialBreakthrough wealth creation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Disc Medicine Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Disc Medicine Inc. stockUnrivaled growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Disc Medicine’s Strategic Advancements and Regulatory Progress Drive Buy Rating - TipRanks

Jul 23, 2025
pulisher
Jul 22, 2025

Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

Disc Medicine’s (IRON) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Disc Medicine's NDA Submission for Bitopertin in EPP: A Catalyst-Driven Opportunity in a High-Unmet-Need Market - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Disc Medicine to submit NDA for bitopertin in EPP in October By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Truist Securities initiates Disc Medicine stock with Buy rating, $86 target - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Disc Medicine to submit NDA for bitopertin in EPP in October - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

Disc Medicine, Inc. Receives Positive FDA Feedback for Bitopertin NDA Submission in Erythropoietic Protoporphyria - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Disc Medicine Announces Positive Pre-NDA Meeting and - GlobeNewswire

Jul 21, 2025
pulisher
Jul 19, 2025

why disc medicine inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Disc Medicine(IRON) Soars 7.28% on Insider Trading, Analyst Rating - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Disc medicine CFO Franchi sells $119k in shares - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Disc medicine CFO Franchi sells $119k in shares By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Raymond James reiterates Strong Buy on Disc Medicine stock amid Bristol Myers trial results - Investing.com Canada

Jul 18, 2025
pulisher
Jul 16, 2025

Why Disc Medicine Inc. stock attracts strong analyst attentionMarket Ready Callouts - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

How Disc Medicine Inc. stock performs during market volatilityCapital Safe Stock Watchlist - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Disc Medicine Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Disc Medicine Elects Nadim Ahmed as Director - The Globe and Mail

Jul 15, 2025

Disc Medicine Inc (IRON) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):